SPRINKLR INC-A (CXM)

US85208T1079 - Common Stock

12.7699  -0.24 (-1.85%)

Fundamental Rating

5

CXM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 279 industry peers in the Software industry. CXM has an excellent financial health rating, but there are some minor concerns on its profitability. CXM is quite expensive at the moment. It does show a decent growth rate.



4

1. Profitability

1.1 Basic Checks

CXM had positive earnings in the past year.
In the past year CXM had a positive cash flow from operations.
CXM had negative earnings in each of the past 5 years.
In multiple years CXM reported negative operating cash flow during the last 5 years.

1.2 Ratios

CXM has a better Return On Assets (2.72%) than 76.62% of its industry peers.
CXM's Return On Equity of 4.49% is fine compared to the rest of the industry. CXM outperforms 76.98% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.57%, CXM is in the better half of the industry, outperforming 71.94% of the companies in the same industry.
Industry RankSector Rank
ROA 2.72%
ROE 4.49%
ROIC 1.57%
ROA(3y)-8.01%
ROA(5y)N/A
ROE(3y)-17.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CXM has a Profit Margin of 4.20%. This is in the better half of the industry: CXM outperforms 76.26% of its industry peers.
CXM has a better Operating Margin (1.95%) than 69.78% of its industry peers.
CXM has a better Gross Margin (75.66%) than 70.86% of its industry peers.
In the last couple of years the Gross Margin of CXM has grown nicely.
Industry RankSector Rank
OM 1.95%
PM (TTM) 4.2%
GM 75.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.84%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

CXM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
There is no outstanding debt for CXM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 5.60 indicates that CXM is not in any danger for bankruptcy at the moment.
CXM's Altman-Z score of 5.60 is fine compared to the rest of the industry. CXM outperforms 70.86% of its industry peers.
There is no outstanding debt for CXM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.6
ROIC/WACC0.17
WACC9.38%

2.3 Liquidity

CXM has a Current Ratio of 2.23. This indicates that CXM is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.23, CXM is doing good in the industry, outperforming 64.39% of the companies in the same industry.
CXM has a Quick Ratio of 2.23. This indicates that CXM is financially healthy and has no problem in meeting its short term obligations.
CXM has a Quick ratio of 2.23. This is in the better half of the industry: CXM outperforms 65.11% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 2.23

6

3. Growth

3.1 Past

CXM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 390.91%, which is quite impressive.
CXM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.53%.
Measured over the past years, CXM shows a very strong growth in Revenue. The Revenue has been growing by 23.99% on average per year.
EPS 1Y (TTM)390.91%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q450%
Revenue 1Y (TTM)19.53%
Revenue growth 3Y23.99%
Revenue growth 5YN/A
Revenue growth Q2Q18.45%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 13.53% on average over the next years. This is quite good.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.99%
Revenue Next 2Y14.15%
Revenue Next 3Y13.53%
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 39.91, CXM can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CXM is valued a bit cheaper than the industry average as 71.22% of the companies are valued more expensively.
CXM is valuated expensively when we compare the Price/Earnings ratio to 26.42, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 33.12, the valuation of CXM can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CXM indicates a somewhat cheap valuation: CXM is cheaper than 68.35% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CXM to the average of the S&P500 Index (22.74), we can say CXM is valued slightly more expensively.
Industry RankSector Rank
PE 39.91
Fwd PE 33.12

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CXM is valued a bit cheaper than the industry average as 65.47% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CXM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 63.41
EV/EBITDA 85.42

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CXM!.
Industry RankSector Rank
Dividend Yield N/A

SPRINKLR INC-A

NYSE:CXM (3/28/2024, 10:09:10 AM)

12.7699

-0.24 (-1.85%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.50B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 39.91
Fwd PE 33.12
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.72%
ROE 4.49%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.95%
PM (TTM) 4.2%
GM 75.66%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.23
Quick Ratio 2.23
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)390.91%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)19.53%
Revenue growth 3Y23.99%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y